跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30,464 条关于
“Oxford Pharmascience Group Plc”
全部
30,464
临床试验
18,871
药物
1,146
机构
2,228
资讯
8,219
10个月前
Adaptimmune Undergoes Major Leadership Restructuring Following Nasdaq Delisting and Asset Divestiture
3年前
hVIVO PLC Develops hMPV Human Challenge Model
去年
Supreme Court of Canada to Rule on Medical Treatment Patent Eligibility in Landmark Pharmascience v Janssen Case
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
去年
COMPASS Pathways Reports Financials and Progress on COMP360 Psilocybin Program
11个月前
Oxford Biomedica Expands US Gene Therapy Manufacturing with $4.5M North Carolina Facility Acquisition
7个月前
Oxford BioMedica Secures Five-Year Commercial Supply Deal with Bristol Myers Squibb for CAR-T Vector Manufacturing
2年前
Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma
去年
Tezspire Meets Primary Endpoints in WAYPOINT Trial for Chronic Rhinosinusitis with Nasal Polyps
去年
Physiomics' PREDICT-ONC Trial Receives Approval to Optimize Chemotherapy Dosing
第 1 页，共 822 页
上一页
下一页
